MXCT vs WY · rev $38.6M vs P/E 43, rev $7.12B
MaxCyte Inc (MXCT) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WY revenue for 2024-12-31 was $7.12B. Net income was $396.0M. Revenue was down 7.2% from 2023-12-31 to 2024-12-31. WY currently screens at market cap $17.54B and trailing P/E 43.4.
MXCT currently screens at market cap $124.3M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the MXCT and WY stock pages for the full models.
Not investment advice.